Dr. Cai’s research mainly focuses on enhancing the effectiveness of cardiac stem cell therapy for ischemic heart disease via genetic modification of protein coding or non-coding genes, or pharmaceutical administration with small molecules. His lab also investigates the role of long noncoding RNAs (lncRNAs) in the cardioprotection.
- PhD: Institute of Biophysics, China, Molecular Biology & Biochemistry
- Fellowship: UMDNJ-Robert Wood Johnson Medical School, U.S., Postdoctoral Fellow in Physiology & Biophysics
- Ischemic heart disease
- Myocardial repair/regeneration
- Cardiac stem/progenitor cells
- Oxidative stress
“Enhancing the effectiveness of human cardiac stem cell therapy”